Literature DB >> 24941378

Clinical grade purification and expansion of natural killer cells.

Natalia Lapteva1, Susann M Szmania2, Frits van Rhee2, Cliona M Rooney1.   

Abstract

Natural killer (NK) cells have been shown to have important functions in anti-tumor responses and therefore have been used as adoptive immunotherapy for cancer. Here, we review the current methods of ex vivo activation, enrichment, expansion, and shipment of clinical NK cell products.

Entities:  

Mesh：

Year:  2014        PMID： 24941378      PMCID： PMC4095851          DOI： 10.1615/critrevoncog.2014010931

Source DB:  PubMed          Journal:  Crit Rev Oncog        ISSN： 0893-9675


  23 in total

1.  Isolation of human lymphocytes by a Ficoll barrier method.

Authors:  W Boyle; A Chow
Journal:  Transfusion       Date:  1969 May-Jun       Impact factor: 3.157

2.  Allogeneic natural killer cells for refractory lymphoma.

Authors:  Veronika Bachanova; Linda J Burns; David H McKenna; Julie Curtsinger; Angela Panoskaltsis-Mortari; Bruce R Lindgren; Sarah Cooley; Daniel Weisdorf; Jeffrey S Miller
Journal:  Cancer Immunol Immunother       Date:  2010-08-03       Impact factor: 6.968

3.  IL-2 activated NK cell immunotherapy of three children after haploidentical stem cell transplantation.

Authors:  Ulrike Koehl; Jan Sörensen; Ruth Esser; Stefanie Zimmermann; Hans Peter Grüttner; Torsten Tonn; Christian Seidl; Erhard Seifried; Thomas Klingebiel; Dirk Schwabe
Journal:  Blood Cells Mol Dis       Date:  2004 Nov-Dec       Impact factor: 3.039

4.  A new method for in vitro expansion of cytotoxic human CD3-CD56+ natural killer cells.

Authors:  S Carlens; M Gilljam; B J Chambers; J Aschan; H Guven; H G Ljunggren; B Christensson; M S Dilber
Journal:  Hum Immunol       Date:  2001-10       Impact factor: 2.850

5.  Infusion of haplo-identical killer immunoglobulin-like receptor ligand mismatched NK cells for relapsed myeloma in the setting of autologous stem cell transplantation.

Authors:  Jumei Shi; Guido Tricot; Susann Szmania; Nancy Rosen; Tarun K Garg; Priyangi A Malaviarachchi; Amberly Moreno; Bo Dupont; Katharine C Hsu; Lee Ann Baxter-Lowe; Michele Cottler-Fox; John D Shaughnessy; Bart Barlogie; Frits van Rhee
Journal:  Br J Haematol       Date:  2008-10-16       Impact factor: 6.998

6.  Expansion of highly cytotoxic human natural killer cells for cancer cell therapy.

Authors:  Hiroyuki Fujisaki; Harumi Kakuda; Noriko Shimasaki; Chihaya Imai; Jing Ma; Timothy Lockey; Paul Eldridge; Wing H Leung; Dario Campana
Journal:  Cancer Res       Date:  2009-04-21       Impact factor: 12.701

7.  Clinical-grade ex vivo-expanded human natural killer cells up-regulate activating receptors and death receptor ligands and have enhanced cytolytic activity against tumor cells.

Authors:  Maria Berg; Andreas Lundqvist; Philip McCoy; Leigh Samsel; Yong Fan; Abdul Tawab; Richard Childs
Journal:  Cytotherapy       Date:  2009       Impact factor: 5.414

8.  Ex vivo expansion of natural killer cells for clinical applications.

Authors:  H-G Klingemann; J Martinson
Journal:  Cytotherapy       Date:  2004       Impact factor: 5.414

9.  Optimization manufacture of virus- and tumor-specific T cells.

Authors:  Natalia Lapteva; Juan F Vera
Journal:  Stem Cells Int       Date:  2011-09-11       Impact factor: 5.443

10.  Clinical-grade generation of active NK cells from cord blood hematopoietic progenitor cells for immunotherapy using a closed-system culture process.

Authors:  Jan Spanholtz; Frank Preijers; Marleen Tordoir; Carel Trilsbeek; Jos Paardekooper; Theo de Witte; Nicolaas Schaap; Harry Dolstra
Journal:  PLoS One       Date:  2011-06-16       Impact factor: 3.240
View more
  19 in total

1.  Fine-tuning the CAR spacer improves T-cell potency.

Authors:  Norihiro Watanabe; Pradip Bajgain; Sujita Sukumaran; Salma Ansari; Helen E Heslop; Cliona M Rooney; Malcolm K Brenner; Ann M Leen; Juan F Vera
Journal:  Oncoimmunology       Date:  2016-11-08       Impact factor: 8.110

Review 2.  Preservation of cell-based immunotherapies for clinical trials.

Authors:  Rui Li; Rachel Johnson; Guanglin Yu; David H McKenna; Allison Hubel
Journal:  Cytotherapy       Date:  2019-08-12       Impact factor: 5.414

3.  Ex vivo-expanded natural killer cells demonstrate robust proliferation in vivo in high-risk relapsed multiple myeloma patients.

Authors:  Susann Szmania; Natalia Lapteva; Tarun Garg; Amy Greenway; Joshuah Lingo; Bijay Nair; Katie Stone; Emily Woods; Junaid Khan; Justin Stivers; Susan Panozzo; Dario Campana; William T Bellamy; Molly Robbins; Joshua Epstein; Shmuel Yaccoby; Sarah Waheed; Adrian Gee; Michele Cottler-Fox; Cliona Rooney; Bart Barlogie; Frits van Rhee
Journal:  J Immunother       Date:  2015-01       Impact factor: 4.456

Review 4.  The Next Generation of Cellular Immunotherapy: Chimeric Antigen Receptor-Natural Killer Cells.

Authors:  Jake Moscarelli; David Zahavi; Rachael Maynard; Louis M Weiner
Journal:  Transplant Cell Ther       Date:  2022-07-03

Review 5.  Natural Killer Cells for Therapy of Leukemia.

Authors:  Garnet Suck; Yeh Ching Linn; Torsten Tonn
Journal:  Transfus Med Hemother       Date:  2016-03-22       Impact factor: 3.747

6.  A Novel Serpin Regulatory Mechanism: SerpinB9 IS REVERSIBLY INHIBITED BY VICINAL DISULFIDE BOND FORMATION IN THE REACTIVE CENTER LOOP.

Authors:  Matthew S J Mangan; Catherina H Bird; Dion Kaiserman; Anthony Y Matthews; Corinne Hitchen; David L Steer; Philip E Thompson; Phillip I Bird
Journal:  J Biol Chem       Date:  2015-12-15       Impact factor: 5.157

7.  A Genetically Engineered Primary Human Natural Killer Cell Platform for Cancer Immunotherapy.

Authors:  Emily J Pomeroy; John T Hunzeker; Mitchell G Kluesner; Walker S Lahr; Branden A Smeester; Margaret R Crosby; Cara-Lin Lonetree; Kenta Yamamoto; Laura Bendzick; Jeffrey S Miller; Melissa A Geller; Bruce Walcheck; Martin Felices; Beau R Webber; Timothy K Starr; Branden S Moriarity
Journal:  Mol Ther       Date:  2019-10-15       Impact factor: 11.454

8.  Human serum albumin and chromatin condensation rescue ex vivo expanded γδ T cells from the effects of cryopreservation.

Authors:  Rebecca E Burnham; Donald Tope; Gianna Branella; Erich Williams; Christopher B Doering; H Trent Spencer
Journal:  Cryobiology       Date:  2021-01-21       Impact factor: 2.487

Review 9.  Natural Killer Cells and Regulatory T Cells Cross Talk in Hepatocellular Carcinoma: Exploring Therapeutic Options for the Next Decade.

Authors:  Amber G Bozward; Frazer Warricker; Ye H Oo; Salim I Khakoo
Journal:  Front Immunol       Date:  2021-04-30       Impact factor: 7.561

Review 10.  Shaping of Natural Killer Cell Antitumor Activity by Ex Vivo Cultivation.

Authors:  Markus Granzin; Juliane Wagner; Ulrike Köhl; Adelheid Cerwenka; Volker Huppert; Evelyn Ullrich
Journal:  Front Immunol       Date:  2017-04-26       Impact factor: 7.561
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.